There is still a lot we don’t know about COVID-19.
The COVID PROFILE study aims to find answers to these and other important questions by comparing immune responses in people who have experienced coronavirus infection, or who have been vaccinated, to people who have not.
These insights will help us better understand the factors that make a person susceptible to COVID-19 and the severity of the illness they might develop.
This will help doctors ensure those most at risk receive appropriate medical care, and will help inform vaccine design and public health measures in the future.
Enrolment for this study has now closed.
For more information see the COVID PROFILE FAQs.
The Australian First Few X (FFX) study aims to understand how emerging COVID-19 variants are transmitted within households and families.
The study will also provide information about:
We are seeking participants from households where:
If you (and your household members) agree to participate, you will:
The FFX study, or ‘First Few X’ (where ‘X’ represents the first identified cases of COVID-19), is designed to help gain an understanding of the infectiousness and severity of COVID-19 in Australia. The Australian FFX study is coordinated through the Australian Department of Health, and is based on a World Health Organization protocol. It is one of many similar studies being conducted worldwide.
WEHI is leading a number of major research responses to COVID-19 in collaboration with research partners in universities, hospitals and the private sector.
Our researchers are working towards better approaches to diagnose, treat and prevent the spread of coronaviruses, both to address the current COVID-19 pandemic, as well as in preparedness for future coronaviral disease outbreaks.
Find out more about WEHI’s COVID-19 response.